Vascular smooth muscle cells in Marfan syndrome aneurysm: the broken bricks in the aortic wall

Area of Science:

• Genetics
• Cardiovascular Medicine
• Cell Biology

Background:

• Marfan syndrome (MFS) is a heritable connective tissue disorder impacting multiple organs.
• It stems from mutations in the FBN1 gene, which encodes fibrillin-1, an extracellular matrix protein crucial for microfibril structure.
• Aortic degeneration, leading to thoracic aortic aneurysm and dissection, is the primary cause of mortality in MFS patients.

Purpose of the Study:

• To review the molecular mechanisms underlying Marfan syndrome pathogenesis.
• To focus on the role of vascular smooth muscle cells in MFS.
• To identify novel therapeutic targets for MFS-related aortic disease.

Main Methods:

• Literature review of molecular mechanisms in Marfan syndrome.
• Analysis of FBN1 gene mutations and their impact on fibrillin-1 and ECM.
• Examination of cellular processes in vascular smooth muscle cells relevant to MFS.

Main Results:

• FBN1 mutations disrupt microfibril structure and extracellular matrix integrity in the aortic tunica media.
• Vascular smooth muscle cells are central to MFS pathogenesis and aortic complications.
• Current primary treatment involves surgical aortic repair.

Conclusions:

• Understanding MFS molecular etiology in vascular smooth muscle cells is key to developing new therapies.
• Targeting these mechanisms may offer alternatives or adjuncts to surgical intervention.
• Further research into cellular pathways could reveal novel therapeutic strategies for Marfan syndrome.